Lv1
74 积分 2025-01-07 加入
https://pubmed.ncbi.nlm.nih.gov/10445158/
3个月前
已关闭
Sample Size Calculations in Clinical Research
6个月前
已关闭
Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies
7个月前
已完结
Species differences in drug transporters and implications for translating preclinical findings to humans
8个月前
已完结
Abstract 6268: TT125-802 is a potent and highly selective CBP/p300 bromodomain inhibitor for the treatment of castration resistant prostate cancer and haematological malignancies
8个月前
已关闭
Chapter 14 - Clinical Pathology in Nonclinical Toxicity Studies
8个月前
已关闭
缓控释制剂非临床药代动力学研究与评价的考虑要点 CDE电子刊物/孙涛/CDE
10个月前
已完结
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
10个月前
已完结
Industry perspective on the nonclinical safety assessment of heterobifunctional degraders
10个月前
已完结
皖公网安备34019202002308
